Showing results 1 to 20 of 59
next >
| Issue Date | Title | Author(s) |
| 2-Sep-2020 | 3D-Printed Modular Hemipelvic Endoprosthetic Reconstruction Following Periacetabular Tumor Resection Early Results of 80 Consecutive Cases | Ji, Tao; Yang, Yi; Tang, Xiaodong; Liang, Haijie; Yan, Taiqiang; Yang, Rongli; Guo, Wei |
| 2017 | Acetabular Reconstruction With Femoral Head Autograft After Intraarticular Resection of Periacetabular Tumors is Durable at Short-term Followup | Tang, Xiaodong; Guo, Wei; Yang, Rongli; Yan, Taiqiang; Tang, Shun; Li, Dasen |
| Jun-2022 | Analysis of mechanical complications for patients with extremity sarcoma after biological reconstruction | Wang, Jun; Du, Zhiye; Yang, Rongli; Tang, Xiaodong; Guo, Wei |
| 2019 | Anlotinib and irinotecan for advanced Ewing sarcoma after failure of standard therapy: A multicenter, two-cohort, single-arm, open label, phase Ib/II trial (NCT03416517). | Xu, Jie; Xie, Lu; Guo, Wei; Tang, Xiaodong; Yang, Rongli; Yan, Taiqiang; Liu, Kuisheng; Gu, Jin |
| Mar-2021 | Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial | Xu, Jie; Xie, Lu; Sun, Xin; Liu, Kuisheng; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Guo, Wei; Gu, Jin |
| 2020 | Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma | Xie, Lu; Xu, Jie; Sun, Xin; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Guo, Wei |
| 2018 | Apatinib for advanced osteosarcoma after failure of standard multimodal therapy: An open label phase 2 clinical trial. | Xie, Lu; Xu, Jie; Sun, Xin; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Guo, Wei |
| 2019 | Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial | Xie, Lu; Xu, Jie; Sun, Xin; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Guo, Wei |
| 2020 | Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study | Xie, Lu; Xu, Jie; Sun, Xin; Liu, Kuisheng; Li, Xiaowei; He, Fangzhou; Liu, Xinyu; Gu, Jin; Lv, Zhe; Yang, Rongli; Tang, Xiaodong; Yan, Taiqiang; Li, Dasen; Yang, Yi; Dong, Sen; Sun, Kunkun; Shen, Danhua; Guo, Wei |
| 2020 | Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial | Xie, Lu; Xu, Jie; Sun, Xin; Guo, Wei; Gu, Jin; Liu, Kuisheng; Zheng, Bingxin; Ren, Tingting; Huang, Yi; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Sun, Kunkun; Shen, Danhua; Li, Yuan |
| 2019 | Apatinib plus camrelizumab (SHR-1210) for unresectable high-grade osteosarcoma (APFAO) progressing after chemotherapy: A prospective, open label, phase II trial. | Xie, Lu; Guo, Wei; Xu, Jie; Sun, Xin; Liu, Kuisheng; Zheng, Bingxin; Ren, Ting; Huang, Yi; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Sun, Kunkun; Shen, Danhua; Li, Yuan |
| Oct-2021 | Assessment of the Viability and Union Feature of Diaphysis Reconstruction Using Pasteurized Tumor Bone and Intramedullary Free Fibular After Tumor Resection | Ji, Tao; Li, Yuan; Xing, Zhili; Tang, Xiaodong; Yang, Rongli; Guo, Wei |
| 2009 | Custom-made prosthesis replacement for reconstruction of elbow after tumor resection | Tang, Xiaodong; Guo, Wei; Yang, Rongli; Tang, Shun; Yang, Yi |
| 2-Nov-2020 | Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma | Zang, Jie; Guo, Wei; Yang, Rongli; Tang, Xiaodong; Liang, Haijie |
| 2019 | Does intramedullary nailing improve the union rate or decrease mechanical complications for patients with extremity sarcoma after biological reconstruction? | Wang, Jun; Yang, Yi; Yang, Rongli; Tang, Xiaodong; Guo, Wei |
| 4-Jul-2022 | Efficacy and safety of a 3D-printed arthrodesis prosthesis for reconstruction after resection of the proximal humerus: preliminary outcomes with a minimum 2-year follow-up | Liang, Haijie; Guo, Wei; Yang, Yi; Li, Dasen; Yang, Rongli; Tang, Xiaodong; Yan, Taiqiang |
| 3-Feb-2024 | The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma | Xie, Lu; Sun, Xin; Xu, Jie; Liang, Xin; Liu, Kuisheng; Sun, Kunkun; Yang, Rongli; Tang, Xiaodong; Guo, Wei |
| 2018 | Enteral nutrition feeding in Chinese intensive care units: a cross-sectional study involving 116 hospitals | Xing, Juan; Zhang, Zhongheng; Ke, Lu; Zhou, Jing; Qin, Bingyu; Liang, Hongkai; Chen, Xiaomei; Liu, Wenming; Liu, Zhongmin; Ai, Yuhang; Wang, Difeng; Wang, Qiuhui; Zhou, Qingshan; Zhang, Fusen; Qian, Kejian; Jiang, Dongpo; Zang, Bin; Li, Yimin; Huang, Xiaobo; Qu, Yan; Xie, Yinguang; Xu, Donglin; Zou, Zhiqiang; Zheng, Xiangde; Liu, Jianbo; Guo, Feng; Liang, Yafeng; Sun, Qiang; Gao, Hongmei; Liu, Yang; Chang, Ping; Ceng, Aibin; Yang, Rongli; Yao, Gaiqi; Sun, Yun; Wang, Xiaorong; Zhang, Yi; Wen, Yichao; Yu, Jian; Sun, Rongqing; Li, Zhiwei; Yuan, Shiyi |
| 12-Nov-2020 | Epidemiological characteristics of 1385 primary sacral tumors in one institution in China | Wang, Jun; Li, Dasen; Yang, Rongli; Tang, Xiaodong; Yan, Taiqiang; Guo, Wei |
| 2009 | Evaluation of blood loss during limb salvage surgery for pelvic tumours | Tang, Xiaodong; Guo, Wei; Yang, Rongli; Tang, Shun; Ji, Tao |
